Skip to main content
NH · Health Care · 2026-08-21

Narayana Hrudayalaya Ltd

3.0WatchWeak -0.2Stage 2 · wk 11In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹1,815.8
+0.92% today
₹36,879 Cr · Large cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.

Visit company website →
P/E (TTM)
48.1
Forward 27.8
Earnings Growth (YoY)
+13.6%
Revenue +82.6%
ROE
+19.8%
Profit margin +10.1%
Dividend Yield
0.24%
P/B 9.6
vs 52W High
-12.7%
₹1,605.3 lo₹2,080.3 hi
12.7% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 11
1w13w26w
Week 11 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
-2.2%
200 DMA: ₹1,856.8 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.69x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
MA20 rolling over · -4.7% vs MA50 -0.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #63 of 84 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #12 of 15 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 48w
S3 15w
S2 37w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 48w → S3 15w → S4 1w → S3 1w → S4 3w → S1 1w → S2 4w → S1 1w → S2 5w → S1 1w → S4 2w → S3 1w → S2 37w → S3 11w → S2 11w → S3 2w → S4 13w → S1 2w → S2 10w current
Total tracked: 168 weeks across 19 stage runs.
1M
-8.4%
3M
-2.1%
6M
-1.1%
YTD
-2.3%
1Y
-0.8%
Scan Membership
Breakout Watch
Latest: 2026-06-10
5 appearances in last 60 days. First seen: 2024-09-12.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 11 · Vol x
2026-08-20S2
Wk 11 · Vol x
2026-08-19S2
Wk 10 · Vol x
2026-08-18S2
Wk 10 · Vol x
2026-08-17S2
Wk 10 · Vol x
2026-08-14S2
Wk 10 · Vol x
2026-08-13S2
Wk 10 · Vol x
2026-08-12S2
Wk 9 · Vol x
2026-08-11S2
Wk 9 · Vol x
2026-08-10S2
Wk 9 · Vol x
2026-08-07S2
Wk 9 · Vol x
2026-08-06S2
Wk 9 · Vol x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹1,938.1
200 DMA
₹1,856.8
52W High
₹2,080.3
52W Low
₹1,605.3
5D Low
₹1,785.7
Resistance levels (recent highs)
20d High
₹2,080.3
60d High
₹2,080.3
120d High
₹2,080.3
250d High
₹2,080.3
Next resistance
+14.6%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.